Stay updated on XmAb®20717 in Selected Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.

Latest updates to the XmAb®20717 in Selected Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision history updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check22 days agoChange DetectedThe header revision was updated from v3.4.2 to v3.4.3. No other content changes are visible.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.4.2 was added to the history, and older notices (lapse in government funding warning and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check57 days agoChange DetectedThe page now displays a site-wide notice about government funding and operating status, and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check64 days agoChange DetectedGlossary toggle added and color-coded highlights (green for additions, red crossed-out for deletions) improve interpretation of changes. The revision label is updated to v3.4.0.SummaryDifference0.9%

- Check79 days agoChange DetectedA new revision entry v3.3.4 was added to the record history and the v3.3.3 entry was removed.SummaryDifference0.1%

Stay in the know with updates to XmAb®20717 in Selected Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.